News | May 07, 2007

Strategic Relationship Formed to Improve Patient Safety Through Medical Information Innovations

May 8, 2007 - OBS Medical and Physio-Control Inc., a wholly-owned subsidiary of Medtronic Inc., announced they have entered into a strategic relationship to improve patient safety through medical information innovations in external defibrillation monitoring technologies.

Under this global strategic relationship, which was announced by both companies at the 3rd International Conference on Rapid Response Systems, Physio-Control will license OBS Medical's BioSign technology to incorporate it into future monitoring and defibrillation products. The two companies will also collaborate in research for medical algorithms to better manage sudden cardiac arrest.

"We are excited to enter into this strategic relationship with Physio-Control, a pioneer and innovator in the global external defibrillation marketplace," said Frank Cheng, president and CEO of OBS Medical. "This is a major step toward ensuring better patient safety in and outside of hospitals. By integrating the BioSign algorithm with Physio-Control's future defibrillation products, we hope to add significant clinical insights for better assessment of patients' clinical conditions, and enable doctors and nurses to identify and respond to critically ill patients more effectively."

"This new strategic relationship is especially exciting to us as we create monitoring and resuscitation solutions for the future," said Brian Webster, president of Physio-Control. "OBS Medical's technology, the BioSign Index, will provide hospital and other clinicians, such as emergency medical services professionals, with an early warning index enabling them to more quickly respond in urgent medical situations when time is of the essence."

Related Content

Resolute Onyx Stent With Improved Radiographic Visibility Found to Be Safe and Effective
News | Stents Drug Eluting | October 01, 2018
October 1, 2018 — Recent results from the BIONYX randomized clinical study showed the novel, thin-strutted, polymer-c
Boston Scientific Receives FDA Approval for Eluvia Drug-Eluting Vascular Stent
Technology | Stents Drug Eluting | October 01, 2018
Boston Scientific announced that the U.S. Food and Drug Administration (FDA) has approved its Premarket Approval (PMA)...
Eluvia Drug-Eluting Stent Demonstrates Superior Patency in IMPERIAL Trial
News | Stents Drug Eluting | September 26, 2018
Positive 12-month data from the late-breaking IMPERIAL trial was presented at the 2018 Transcatheter Cardiovascular...
Titanium-Nitride-Oxide Stent Superior to Bioabsorbable DES in Acute Coronary Syndrome Patients

Image courtesy of Hexacath

News | Stents Drug Eluting | May 31, 2018
Late-breaking trial results presented at the EuroPCR Congress, May 21-24 in Paris, France, found the Optimax titanium-...
Orsiro DES Shows Lowest Two-Year Target Lesion Failure in BIO-RESORT Trial
News | Stents Drug Eluting | May 31, 2018
Two-year outcome data from the BIO-RESORT randomized controlled trial were presented in a late-breaking clinical trials...
OCT Reveals Excellent Healing Profile for Complex CAD Patients With Resolute Onyx DES
News | Stents Drug Eluting | May 29, 2018
Investigators recently unveiled clinical data from the independently run Onyx 1-Month OCT Study showing strong early...
Abbott's Xience Sierra Stent Receives FDA Approval
Technology | Stents Drug Eluting | May 25, 2018
Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for Xience Sierra, the newest...
Medtronic Launches 2 mm Onyx DES
Technology | Stents Drug Eluting | February 26, 2018
February 26, 2018 – Designed specifically for small vessels, Medtronic plc announced U.S.
Detroit Medical Center Heart Hospital Uses Michigan's First EluNIR Drug-Eluting Stent
News | Stents Drug Eluting | February 19, 2018
February 19, 2018 — The Detroit Medical Center’s (DMC) interventional cardiology team at Heart Hospital recently beca
Biotronik Symposium Highlights Differing Roles of Drug-Eluting Stents and Magnesium Scaffolds in Clinical Practice
News | Stents Drug Eluting | January 25, 2018
January 25, 2018 – Data presented at the Biotronik-sponsored...
Overlay Init